Ulisse Biomed SpA
UBM
Company Profile
Business description
Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.
Contact
Area Science Park - SS14 km.163, 5
Basovizza34149
ITASector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
2
Stocks News & Analysis
stocks
Has the most hated company on the ASX 200 bounced back?
Encouraging results indicate a potential turnaround story.
stocks
Amazon earnings: Good results, with AWS still a winner; fear on profitability guidance is overblown
We think Amazon stock looks attractive.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,922.00 | 77.00 | -0.86% |
| CAC 40 | 7,604.00 | 57.84 | 0.77% |
| DAX 40 | 23,621.64 | 195.67 | 0.84% |
| Dow JONES (US) | 43,588.58 | 542.40 | -1.23% |
| FTSE 100 | 9,083.88 | 48.93 | -0.54% |
| HKSE | 24,710.78 | 62.55 | -0.25% |
| NASDAQ | 20,650.13 | 472.31 | -2.24% |
| Nikkei 225 | 40,290.70 | 779.12 | -1.90% |
| NZX 50 Index | 12,684.04 | 139.70 | -1.09% |
| S&P 500 | 6,238.01 | 101.38 | -1.60% |
| S&P/ASX 200 | 8,663.70 | 79.10 | -0.90% |
| SSE Composite Index | 3,583.31 | 23.36 | 0.66% |